1. Small molecule inhibitors that selectively block dengue virus methyltransferase.
- Author
-
Lim SP, Sonntag LS, Noble C, Nilar SH, Ng RH, Zou G, Monaghan P, Chung KY, Dong H, Liu B, Bodenreider C, Lee G, Ding M, Chan WL, Wang G, Jian YL, Chao AT, Lescar J, Yin Z, Vedananda TR, Keller TH, and Shi PY
- Subjects
- Antiviral Agents pharmacology, Binding Sites, Crystallography, X-Ray, Dengue drug therapy, Dengue enzymology, Dengue genetics, Dengue Virus genetics, Enzyme Inhibitors pharmacology, Humans, Methyltransferases genetics, Methyltransferases metabolism, S-Adenosylmethionine pharmacology, Viral Proteins genetics, Viral Proteins metabolism, Antiviral Agents chemistry, Dengue Virus enzymology, Enzyme Inhibitors chemistry, Methyltransferases antagonists & inhibitors, Methyltransferases chemistry, S-Adenosylmethionine analogs & derivatives, S-Adenosylmethionine chemistry, Viral Proteins antagonists & inhibitors, Viral Proteins chemistry
- Abstract
Crystal structure analysis of Flavivirus methyltransferases uncovered a flavivirus-conserved cavity located next to the binding site for its cofactor, S-adenosyl-methionine (SAM). Chemical derivatization of S-adenosyl-homocysteine (SAH), the product inhibitor of the methylation reaction, with substituents that extend into the identified cavity, generated inhibitors that showed improved and selective activity against dengue virus methyltransferase (MTase), but not related human enzymes. Crystal structure of dengue virus MTase with a bound SAH derivative revealed that its N6-substituent bound in this cavity and induced conformation changes in residues lining the pocket. These findings demonstrate that one of the major hurdles for the development of methyltransferase-based therapeutics, namely selectivity for disease-related methyltransferases, can be overcome.
- Published
- 2011
- Full Text
- View/download PDF